The FDA has approved the use of weight loss drugs in people with a BMI of 30 or as low as 27 in some people who have illnesses related to obesity, like diabetes or heart disease. The BMI is a ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

Why Mounjaro Tops Ozempic for Weight Loss In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

Experts said that the novel combination of a GLP-1 and amylin analogue will help obese patients with and without diabetes ...

Weight loss can be a powerful tool to manage diabetes, particularly those with type 2. We’ll discuss research-backed benefits and tips.

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

Have you heard people say that when you lose weight, your stomach decreases in size? As it turns out, the process is a bit ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Metformin is a type 2 diabetes medication which may impact weight loss. Read our expert guide on how metformin works and its potential impact on weight loss.

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

Since the dawn of the Internet (and probably well before), there have been several solutions sold for weight management — including vitamins for weight loss. One in particular, vitamin B12 ...